Elisa Fabbri1, Yang An2, Marta Gonzalez-Freire3, Marco Zoli4, Marcello Maggio5, Stephanie A Studenski3, Josephine M Egan6, Chee W Chia6, Luigi Ferrucci3. 1. Translational Gerontology Branch, Longitudinal Study Section, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland. Department of Medical and Surgical Sciences, University of Bologna, Italy. elisa.fabbri@nih.gov. 2. Laboratory of Behavioral Neuroscience, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland. 3. Translational Gerontology Branch, Longitudinal Study Section, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland. 4. Department of Medical and Surgical Sciences, University of Bologna, Italy. 5. Department of Clinical and Experimental Medicine, University of Parma, Italy. 6. Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Abstract
BACKGROUND: Age-related changes in testosterone levels in older persons and especially in women have not been fully explored. The objective of this study was to describe age-related trajectories of total testosterone (TT), ammonium sulfate precipitation-measured bioavailable testosterone (mBT), and sex hormone-binding glycoprotein (SHBG) in men and women from the Baltimore Longitudinal Study of Aging, with special focus on the oldest adults. METHODS: Participants included 788 White men and women aged 30-96 years with excellent representation of old and oldest old, who reported not taking medications known to interfere with testosterone. Longitudinal data were included when available. TT, mBT, and SHBG were assayed. Age-related trajectories of mBT were compared with those obtained using calculated bioavailable testosterone (cBT). Generalized least square models were performed to describe age-related trajectories of TT, mBT, and SHBG in men and women. RESULTS: mBT linearly declines over the life span and even at older ages in both sexes. In men, TT remains quite stable until the age of 70 years and then declines at older ages, whereas in women TT progressively declines in premenopausal years and slightly increases at older ages. Differences in age-related trajectories between total and bioavailable testosterone are only partially explained by age changes in SHBG, whose levels increases at accelerated rates in old persons. Noteworthy, although mBT and cBT highly correlated with one another, mBT is a much stronger correlate of chronological age than cBT. CONCLUSION: In both men and women, mBT linearly declines over the life span and even at old ages. Its relationship with age-related phenotypes should be further investigated. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
BACKGROUND: Age-related changes in testosterone levels in older persons and especially in women have not been fully explored. The objective of this study was to describe age-related trajectories of total testosterone (TT), ammonium sulfate precipitation-measured bioavailable testosterone (mBT), and sex hormone-binding glycoprotein (SHBG) in men and women from the Baltimore Longitudinal Study of Aging, with special focus on the oldest adults. METHODS:Participants included 788 White men and women aged 30-96 years with excellent representation of old and oldest old, who reported not taking medications known to interfere with testosterone. Longitudinal data were included when available. TT, mBT, and SHBG were assayed. Age-related trajectories of mBT were compared with those obtained using calculated bioavailable testosterone (cBT). Generalized least square models were performed to describe age-related trajectories of TT, mBT, and SHBG in men and women. RESULTS: mBT linearly declines over the life span and even at older ages in both sexes. In men, TT remains quite stable until the age of 70 years and then declines at older ages, whereas in womenTT progressively declines in premenopausal years and slightly increases at older ages. Differences in age-related trajectories between total and bioavailable testosterone are only partially explained by age changes in SHBG, whose levels increases at accelerated rates in old persons. Noteworthy, although mBT and cBT highly correlated with one another, mBT is a much stronger correlate of chronological age than cBT. CONCLUSION: In both men and women, mBT linearly declines over the life span and even at old ages. Its relationship with age-related phenotypes should be further investigated. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
Entities:
Keywords:
Aging; Men; Testosterone; Trajectories; Women
Authors: Sanjay Asthana; Shalendar Bhasin; Robert N Butler; Howard Fillit; Joel Finkelstein; S Mitchell Harman; Lana Holstein; Stanley G Korenman; Alvin M Matsumoto; John E Morley; Panayiotis Tsitouras; Randall Urban Journal: J Gerontol A Biol Sci Med Sci Date: 2004-05 Impact factor: 6.053
Authors: Annette Hammes; Thomas K Andreassen; Robert Spoelgen; Jens Raila; Norbert Hubner; Herbert Schulz; Jochen Metzger; Florian J Schweigert; Peter B Luppa; Anders Nykjaer; Thomas E Willnow Journal: Cell Date: 2005-09-09 Impact factor: 41.582
Authors: Thomas G Travison; Andre B Araujo; Varant Kupelian; Amy B O'Donnell; John B McKinlay Journal: J Clin Endocrinol Metab Date: 2006-12-05 Impact factor: 5.958
Authors: B Lapauw; S Goemaere; H Zmierczak; I Van Pottelbergh; A Mahmoud; Y Taes; D De Bacquer; S Vansteelandt; J M Kaufman Journal: Eur J Endocrinol Date: 2008-07-01 Impact factor: 6.664
Authors: Gideon Sartorius; Sasa Spasevska; Amanda Idan; Leo Turner; Elise Forbes; Anna Zamojska; Carolyn A Allan; Lam P Ly; Ann J Conway; Robert I McLachlan; David J Handelsman Journal: Clin Endocrinol (Oxf) Date: 2012-11 Impact factor: 3.478
Authors: Jenny Pena Dias; Sabina A Haberlen; Adrian S Dobs; Jordan E Lake; Frank J Palella; Lawrence A Kingsley; Jennifer C Price; Shehzad Basaria; Ravi Varadhan; Joseph B Margolick; Chloe L Thio; Todd T Brown Journal: J Acquir Immune Defic Syndr Date: 2021-08-15 Impact factor: 3.771